1 Result(s)

Article

MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells

Current treatment for patients with metastatic melanoma include molecular-targeted therapies and immune checkpoint inhibitors. However, a subset of melanomas are difficult-to-treat. These melanomas include tho...

Nabanita Mukherjee, Jenette Skees, Kaleb J. Todd, Drake A. West… in Cell Death & Disease (2020)